P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
Mercoledì 16 giugno 2021
circa 1 minuti di lettura
Journal and Affiliations:
BMJ, 16 giugno 2021
Marco Valgimigli, Cardiocentro Ticino, EOC, Lugano
Tags:
dual antiplatelet therapy
oronary revascularisation
P2Y12 inhibitor monotherapy
Authors:
Marco Valgimigli